Cargando…

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice

BACKGROUND: We have demonstrated that vaccination with pDNA encoding cysteine proteinase Type II (CPA) and Type I (CPB) with its unusual C-terminal extension (CTE) can partially protect BALB/c mice against cutaneous leishmanial infection. Unfortunately, this protection is insufficient to completely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doroud, Delaram, Zahedifard, Farnaz, Vatanara, Alireza, Taslimi, Yasaman, Vahabpour, Rouholah, Torkashvand, Fatemeh, Vaziri, Behrooz, Rouholamini Najafabadi, Abdolhossein, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134432/ https://www.ncbi.nlm.nih.gov/pubmed/21765963 http://dx.doi.org/10.1371/journal.pntd.0001236

Ejemplares similares

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014)

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

A comparative study on the physicochemical and biological stability of IgG(1) and monoclonal antibodies during spray drying process
por: Ramezani, Vahid, et al.
Publicado: (2014)

Clarithromycin Dissolution Enhancement by Preparation of Aqueous Nanosuspensions Using Sonoprecipitation Technique
por: Esfandi, Es ׳hagh, et al.
Publicado: (2014)

Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design
por: Ghasemian, Elham, et al.
Publicado: (2013)

Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum
por: Habibzadeh, Sima, et al.
Publicado: (2021)

Optimization and characterization of spray-dried IgG formulations: a design of experiment approach
por: Faghihi, Homa, et al.
Publicado: (2017)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022)

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
por: Kalantarian, Pardis, et al.
Publicado: (2010)

The Complete CPA Reference
por: Dauber, Nick
Publicado: (2012)

Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice
por: Davarpanah, Elaheh, et al.
Publicado: (2020)

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
por: Taslimi, Yasaman, et al.
Publicado: (2017)

Structural basis for effects of CpA modifications on C/EBPβ binding of DNA
por: Yang, Jie, et al.
Publicado: (2019)

Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique
por: Daman, Zahra, et al.
Publicado: (2014)

Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice
por: Yazdanian, Maryam, et al.
Publicado: (2015)

CPB-3 and CGH-1 localize to motile particles within dendrites in C. elegans PVD sensory neurons
por: Spendier, Kathrin, et al.
Publicado: (2021)

Detrimental effect of cardiopulmonary bypass(CPB) on malignant disease
por: Darwazah, Ahmad K, et al.
Publicado: (2011)

Recovery of cefazolin and clindamycin in in vitro pediatric CPB systems
por: Zeilmaker‐Roest, Gerdien A., et al.
Publicado: (2020)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Novel Selective and Low-Toxic Inhibitor of LmCPB2.8ΔCTE (CPB) One Important Cysteine Protease for Leishmania Virulence
por: Moreira, Vitor Partite, et al.
Publicado: (2022)

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
por: Badirzadeh, Alireza, et al.
Publicado: (2017)

Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)

The evolutionary history of topological variations in the CPA/AT transporters
por: Sudha, Govindarajan, et al.
Publicado: (2021)

The cardiopulmonary bypass supported high-risk PTCA (CPB-PTCA): a useful model for the study of CPB-dependent systemic inflammatory response syndrome (SIRS)?
por: Prondzinsky, R, et al.
Publicado: (1997)

High Expression of Methylotrophic Yeast-Derived Recombinant Human Erythropoietin in a pH-Controlled Batch System
por: Maleki, Ahmad, et al.
Publicado: (2010)

Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L. tropica
por: Taslimi, Yasaman, et al.
Publicado: (2023)

Leukocyte Depletion During CPB: Effects on Inflammation and Lung Function
por: de Amorim, Célio Gomes, et al.
Publicado: (2013)

Evaluation of Immunogenicity of Novel Isoform of EG95 (EG95-5G1) From Echinococcus granulosus in BALB/C Mice
por: PIRESTANI, Majid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4bl7qiqif7c68eg6gbfkbmqne1